Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Long-Term Safety of Febuxostat in Subjects With Gout. [Phase 2]

View source ↗

Summary

Phase 2 long-term safety results for febuxostat in gout patients; the trial was completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2009-07-16